CTLA4 and triple-A syndrome: Considering that the Th1 immune response promotes atherosclerosis, our findings suggest that intervention to enhance CTLA-4 function could be an attractive strategy to treat patients with AAA who are at high risk of atherosclerotic cardiovascular disease.